Remove 2019 Remove Cannabis Remove Medicine Remove Treatment
article thumbnail

Luxembourg facing three types of medicinal cannabis bottlenecks / shortages

Cannabis Law Report

Luxembourg is scrambling to secure a new medical cannabis supplier after encountering delays of up to 60 days, leaving new patients empty-handed. Health minister Paulette Lenert (LSAP) responded to a parliamentary question that the country was facing three types of medicinal cannabis bottlenecks. Website Delano reports.

Medicine 104
article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

House Veterans Affairs Committee Passes Multiple Marijuana Bills

NORML

On March 12th, the House Veterans Affairs Committee (HVAC) passed two separate pieces of legislation pertaining to cannabis policy. The second bill, HR 1647 , known as the Veterans Equal Access Act of 2019, would allow V.A. We must reform our federal cannabis policy.” Presently, V.A.

Marijuana 363
article thumbnail

Virginia: New Medical Cannabis Laws Take Effect July 1

NORML

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law 260
article thumbnail

Doctors Get New Clinical Guidelines for Managing Chronic Pain With Cannabis, Courtesy of Canadian Researchers

Veriheal

Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronic pain relief have been somewhat hazy…up until now. New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. The team peered into the findings of numerous articles published between 2001 and 2019.

article thumbnail

Use of Cannabis-based medicinal products: NICE guidelines

Cannabis Law Report

Cannabis-based medicinal products. NICE guideline [NG144] Published date: November 2019. Severe treatment-resistant epilepsy. Severe treatment-resistant epilepsy. Tools and resources. Recommendations. Recommendations for research. Rationale and impact. Finding more information and committee details. Chronic pain.

article thumbnail

Brazil authorizes use of medicine derived from marijuana imported from Colombia

Cannabis Law Report

The authorization for the marketing and use of the medicine in Brazil, that can be sold exclusively in pharmacies and with a prescription , is foreseen in a resolution of the National Health Surveillance Agency (Anvisa, regulator) published this Friday in the Official Gazette. Source: [link].